Influence of endothelial cell protein C receptor on plasma clearance of factor VIIa

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 5, 2012, Pages 971-973

  Gopalakrishnan, R ^a   Pendurthi, U R ^a   Hedner, U ^b   Agerso H ^c   Esmon, C T ^d   Rao, L V M ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NOVO NORDISK A S   (Denmark)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 7A; ENDOTHELIAL CELL PROTEIN C RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

BIOAVAILABILITY; CLEARANCE; HUMAN; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VASCULAR ENDOTHELIUM;

ANIMALS; BIOLOGICAL AVAILABILITY; FACTOR VIIA; GENOTYPE; GLYCOPROTEINS; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHENOTYPE; RECOMBINANT PROTEINS;

EID: 84860425038     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04670.x     Document Type: Letter

References (13)

1. Loeliger EA, van der Esch B, Ter Haar Romney-Wachter CC, Booij HL. Factor VII its turnover rate and its possible role in thrombogenesis. Thromb Diath Haemorrh 1960; 4: 196-200.
2. Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2000; 26: 385-91.
3. Petersen LC, Elm T, Ezban M, Krogh TN, Karpf DM, Steino A, Olsen EH, Sorensen BB. Plasma elimination kinetics for factor VII are independent of its activation to factor VIIa and complex formation with plasma inhibitors. Thromb Haemost 2009; 101: 818-26.
4. Agerso H, Brophy DF, Pelzer H, Martin EJ, Carr M, Hedner U, Ezban M. Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients. J Thromb Haemost 2011; 9: 330-8.
5. Agerso H, Kristensen NR, Ostergaard H, Karpf DM, Hermit MB, Pelzer H, Petersen LC, Ezban M. Clearance of rFVIIa and NN1731 after intravenous administration of Beagle dogs. Eur J Pharm Sci 2011; 42: 578-83.
6. Preston RJ, Ajzner E, Razzari C, Karageorgi S, Dua S, Dahlback B, Lane DA. Multifunctional specificity of the protein C/activated protein C Gla domain. J Biol Chem 2006; 281: 28850-7.
7. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 2007; 282: 11849-57.
8. Lopez-Sagaseta J, Montes R, Puy C, Diez N, Fukudome K, Hermida J. Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J Thromb Haemost 2007; 5: 1817-24.
9. Nayak RC, Sen P, Ghosh S, Gopalakrishnan R, Esmon CT, Pendurthi UR, Rao LVM. Endothelial cell protein C receptor cellular localization and trafficking. Blood 2009; 114: 1974-86.
10. Puy C, Hermida J, Montes R. Factor X and factor VII binding to endothelial protein C receptor differs between species. J Thromb Haemost 2011; 9: 1255-7.
11. Sen P, Clark CA, Gopalakrishnan R, Hedner U, Esmon CT, Pendurthi UR, Rao LVM. Factor VIIa binding to endothelial cell protien C receptor: differences between mouse and human systems. Thromb Haemost 2012; DOI: 10.1160/TH11-09-0672.
12. Li W, Zheng X, Gu JM, Ferrell GL, Brady M, Esmon NL, Esmon CT. Extraembryonic expression of EPCR is essential for embryonic viability. Blood 2005; 106: 2716-22.
13. Li W, Zheng X, Gu J, Hunter J, Ferrell GL, Lupu F, Esmon NL, Esmon CT. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost 2005; 3: 1351-9.